What will it take for a clinical-stage biotech to break into the cardio space? One CEO thinks he has the answer.

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Symptoms of NAION can include blurred vision, peripheral vision loss, dark spots in vision, and changes in color perception. Though the exact mechanism is not fully understood, researchers hypothesize ...

World-Renowned Bariatric Surgeon Dr. Amit Taggar Tampa's newest weight loss center offers advanced robotic bariatric surgery, free ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

Watch for: Numbness or weakness, especially on just one side of the body Confusion, difficulty speaking, or trouble understanding other people Vision problems in one or both eyes Dizziness, loss ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

The main results of the SUMMIT trial, reported last year, showed that tirzepatide—a dual glucose-dependent insulinotropic ...

Experts warn Ozempic and Mounjaro may cause sudden, irreversible blindness as patients report vision loss after taking the weight loss drugs.

Eli Lilly expects to provide results from a study in people with obesity and osteoarthritis of the knee in 2025.

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Eli Lilly said it expects to release data from a late-stage trial on its next-generation weight loss drug retatrutide in 2025, a few months earlier than expected. The company expects to provide ...